Related Experiment Video
Updated: Jul 3, 2026
A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
Published on: March 8, 2022
Recent patents on melanoma with focus on genetic strategies
Talia Gramiccia1, Rosita Saraceno, Alessandro D Stefani
1Department of Dermatology, University of Rome Tor Vergata, Rome, Italy.
Abstract:
Recent advances in molecular biology have enhanced the understanding of the pathology of melanocytic lesions. Several targetable pathways, responsible for survival and apoptosis resistance in melanoma cells, have been described and current research has focused on mechanism inactivating these pathways. However, the therapeutic resistance of malignant melanoma remains the main limit that cast the poor prognosis of cutaneous melanoma. Current advances in high-resolution genome-wide technologies, as well as gene-specific mutational analysis, in conjunction with genetic and phenotypic analyses, improved animal models, may ultimately help to better define the seminal molecular events contributing to disease pathogenesis and ultimately identify more effective therapeutic targets. The focus of this review is to summarize the emerging patents in the treatment and diagnosis of melanoma related to the latest genetic models and bio-molecular discoveries.
Insights
This review explores new patents for melanoma treatment and diagnosis, focusing on genetic models and molecular discoveries to overcome therapeutic resistance in cutaneous melanoma.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Melanoma cell survival and apoptosis resistance involve targetable pathways.
- Therapeutic resistance in malignant melanoma contributes to poor prognosis.
- Advances in molecular biology deepen the understanding of melanocytic lesions.
Purpose of the Study:
- To review emerging patents in melanoma treatment and diagnosis.
- To highlight the impact of genetic models and bio-molecular discoveries.
- To address therapeutic resistance in cutaneous melanoma.
Main Methods:
- Review of recent scientific literature and patent databases.
- Analysis of genetic and phenotypic data.
- Integration of findings from high-resolution genome-wide technologies and gene-specific mutational analysis.
Main Results:
- Identification of emerging therapeutic targets and diagnostic strategies for melanoma.
- Summary of patented approaches based on latest genetic models.
- Insights into bio-molecular discoveries influencing melanoma treatment.
Conclusions:
- New genetic models and bio-molecular discoveries offer potential for improved melanoma therapies.
- Patented innovations aim to overcome therapeutic resistance.
- Continued research is crucial for defining molecular events and identifying effective targets.
More Related Videos
Related Concept Videos
02:46Genetic Screens
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...
02:50Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
02:57Targeted Cancer Therapies
There are several types of targeted therapies against specific...
01:30Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...